Acromegaly Market Size Estimation by Top Manufacturer, Latest Trends and Global industry Forecast 2019 to 2023

Acromegaly Market Information: By Types (Ectopic Acromegaly, Acromegaly Due to Growth Hormone), By Diagnosis (Medical Imaging, Medical Laboratory Investigations), By Treatment (Medications, Surgery, Radiation Therapy), By End Users (Hospitals, Clinics) - Global Forecast till 2023

The major driving factors for the market are increasing prevalence of acromegaly, changing lifestyle, and increasing genetic incident of genetic diseases. Moreover, increasing prevalence of hormonal diseases, for instance, endocrine diseases, and hypopituitarism, increasing government support and rapid developments in technology have fuelled the growth of the market. On the other hand, surgical costs is high, which ranges from approximately USD 2,800 to USD 9,200, however, when averaged it is less than the cost of medications. Unavailability of precise treatment and high cost of the surgery may restrain the growth of the market.

The global acromegaly market is expected to grow at a CAGR of ~5.2 % during the forecast period 2017-2023.

Acromegaly is a hormonal disorder that results from heavy secretion of growth hormones (GH) in the body. The pituitary gland in the brain, secretes GH. In acromegaly, the pituitary produces excessive amounts of GH. Usually the excess GH comes from benign, or noncancerous, tumors on the pituitary. These benign tumors are called adenomas. Acromegaly is one of the rare diseases, which most often diagnosed in the middle-aged adults and affects 5-8 people per 1 lakh people. If the diseases is not treated, it can result in serious illness and premature death. The most serious health consequences of the disease may result into high blood pressure, type 2 diabetes, increased risk of cardiovascular disease, arthritis, and others.

Key Players

• Novartis AG (Switzerland),
• Aegis Therapeutics LLC (US),
• Chiasma Inc (US),
• Crinetics Pharmaceuticals Inc (US),
• Daewoong Pharmaceutical Co Ltd (South Korea),
• Peptron Inc (South Korea),
• Silence Therapeutics Plc (UK),
• Strongbridge Biopharma plc (US),
• Amryt Pharma plc (UK),
• Foresee Pharmaceuticals LLC (US),
• Glide Pharmaceutical Technologies Ltd (US),
• Ionis Pharmaceuticals Inc (US),
• Ipsen SA (France)

Segmentation

Acromegaly market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of treatment, the market is segmented into medications, surgery, radiation therapy, and others. The medication is further segmented into somatostatin analogues, dopamine agonists, growth hormone receptor antagonists, and others. The surgery is further segmented into endonasal transphenoidal surgery, and transphenoidal surgery.

On the basis of diagnosis, the market is segmented into medical imaging, medical laboratory investigations, others. The medical imaging is further segmented into radiography, magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and others.

On the basis of type, the market is segmented into ectopic acromegaly, acromegaly due to growth hormone, and others.

Regional Analysis

Asia Pacific is the fastest growing acromegaly market. China, and India are the significant contributors to the market growth due to the presence of huge population base, increasing prevalence of acromegaly, rapidly growing healthcare sector, and increasing healthcare expenditure. Whereas, the Middle East & Africa holds the least share of the global market due to poor economic condition and limited availability of medical facilities in African region. The Middle East & African acromegaly market is majorly driven by the UAE, Saudi Arabia, and Kuwait.

The Americas commands the global market owing to increasing prevalence of acromegaly, large patient population, high healthcare spending, and strong government support for research & development. According to the Health Research Funding Organization, in America, over 3,000 new cases of acromegaly occurs per year.

Europe leads the second position of the global the market, which is followed by Asia Pacific. High healthcare expenditure, well developed healthcare sector, and increasing government support drives the growth of the market.

Browse Premium Research Report Enabled with List of Tables and Figures at @ https://www.marketresearchfuture.com/reports/acromegaly-market-4429

Asia-Pacific Medical Suction Device Market Size Estimation by Top Manufacturer, Latest Trends and Global industry Forecast 2019 to 2023

Asia-Pacific Medical Suction Device Market - Highlights

MRFR is the Leading Brand in The Research Company who Recently Published Asia-Pacific Medical Suction Device Market Research Report. The Medical Suction Device is basically fitted into hospital for the many medical reasons. A Medical Suction machine is device used for the respiratory conditions. The Asia-Pacific market of Medical Suction Device s is expected to grow with a CAGR of 7% during the forecasted period 2017-2023.

The Respiratory conditions like generally results into secretion of mucous, serum that has to be removed for the body. The device is used to remove serum or mucous when the patient is not able to secrete it out from the body. Also, the suction machines are used for several other reasons for example, while operative procedures, delivery of baby.

The Asia-Pacific market of Medical Suction Device Market is growing because of the rising prevalence of diabetes which requires the insulin suction devices, whereas the increasing pollution in the countries are creating the demand for respiratory suction devices.

The medical suction device is basically fitted into hospital for the many medical reasons. A medical suction machine is device used for the respiratory conditions. The respiratory conditions like generally results into secretion of mucous, serum that has to be removed for the body. The device is used to remove serum or mucous when the patient is not able to secrete it out from the body. Also the suction machines are used for several other reasons for example, while operative procedures, delivery of baby. The suction machine utilizes a long catheter to vacuum out the blocking secretions. The secreted material is collected into a jar and then emptied after the process is done. The suction machine work on the power/electric supply or on the battery power. The power required for the machine is 110volts. Batteries of this volts are also available so that the patients can use the device when there is no power supply. The cleaning and replacement of the parts of the machine is very necessary as the machine is used for the patient. So as to maintain the cleanliness the suction machines are cleaned after every use. The cleaning of the machine parts are easy. The machine also has a bacterial filters that are also replaceable and can be replaced very month.

The Asia-Pacific market of Medical Suction Device is growing because of the rising prevalence of diabetes which requires the insulin suction devices, whereas the increasing pollution in the countries are creating the demand for respiratory suction devices. The Asia-Pacific market of Medical Suction Device s is expected to grow with a CAGR of 7% during the forecasted period 2017-2023.

Asia-Pacific Medical Suction Device Market - Key Players

Some of the major players in this market are: De Vilbiss Healthcare, Fluke Biomedical, Yang Zhou Huike Electronic, Allied Healthcare Products. Inc, Olympus Corporation, Gemmy Industrial Corp., Ohio Medical, ATMOS Medizin Tchnik, INTEGRA biosciences, Medicop Inc. and others

Asia-Pacific Medical Suction Device Market - Study Objectives

• To provide detailed study of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Medical Suction Device market.
• To provide insights about factors affecting the market growth.
• To analyze the Medical Suction Device market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies of Asia-Pacific, and countries in this region like, Japan, China, India, Republic of Korea, Rest of Asia and Pacific.

Asia-Pacific Medical Suction Device Market - Segments

Asia-Pacific Medical Suction Device market has been segmented on the basis of types which comprises of types, usage and suctions parts. On the basis of types there are two major types movable and electrical suction device. On the basis of the usage airway suctioning, gastrointestinal decompression, pleural suctioning, operative suctioning and others. On the basis of the suction parts vacuum pumps, bacterial filter, vacuum gauge, moisture or debris trap, suction catheter and others.

Asia-Pacific Medical Suction Device Market - Regional Analysis

Asia-Pacific region is divided into two major regions, Asia and Pacific. Further Asia is divided into the Countries like Japan, China, India, Republic of Korea, and Rest of Asia. The Asia-Pacific market for Medical Suction Device is estimated to grow at a rapid pace during the forecasted period 2017-2023. This is due to increasing number in the technology adoption for the medical devices and the homecare devices. The large number of the respiratory suction devices are in great demand. Countries like China and India have increasing number of chronic respiratory diseases. The increasing number of diabetes in India have a great demand for the insulin suction devices.

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-reportb

Europe and Africa Medical Suction Device Market World Leading Key Players Revenue, Share, Analysis and Estimation Till 2021

Europe Medical Suction Device Market - Scenario:

Europe, the Middle East and Africa Medical Suction Device Market– Forecast to 2021 The report firstly introduced Europe, the Middle East and Africa Medical Suction Device Market including classification, application and industry chain overview; Then we deeply analyzed Europe, the Middle East and Africa growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc. In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Medical Suction Device Market. We are thankful for the support and assistance from America’s medical suctions device. Industry chain related technical experts and marketing experts during Research Team survey and interviews. The report provides comprehensive view about the insomnia Market.

Segmentation

The reports includes following segments:
Portability Type
• Centralized
• Stationary
• Portable Application
• Airway Clearance
• Negative-pressure wound therapy (NPWT)
• Surgical Suction
• Research & Diagnostic Power Mode
• Battery
o DC
o Dual
• Manual

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

Liquid Biopsy Market 2020 Global Regional Outlook, End User, Development, Technology, Innovation, Segmentation, Strategy, Size, Share, Growth Opportunities, Latest Trends Forecast to 2023

Liquid Biopsy Market Research Report: Information by Biomarker Types (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CTDNA), Extracellular Vesicles (EVS) and other Biomarker (Circulating RNA and Proteins)), Application (Cancer Therapeutic Application, Reproductive Health and Other Therapeutic Application), Sample (Blood Sample, Urine Sample and other), End User (Hospitals and Laboratories, Academic and Research Centers and other End Users) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast to 2022

Market Insights:

Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.

Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart.

Segmentation:

Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.

Major Players

·         Guardant Health, Inc.,

·         Trovagene, Inc.,

·         RainDance Technologies, Inc.,

·         Agena Bioscience Inc. Inc.,

·         Admera Health,

·         Biocept, Inc.,

·         Circulogene Theranostics,

·         Inivata Ltd.,

·         SAGA Diagnostics AB,

·         Exosome Diagnostics and others.

Drivers

The market drivers for the liquid biopsy market are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Also the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.

Regional Analysis:

Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.

Key findings

• Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.
• On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
• The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period

Browse More Healthcare Reports @

https://www.marketresearchfuture.com/categories/healthcare-market-report

Global Over-The-Wire Micro-Guide Catheter Market Trends, Demand and Forecast to 2023

Global Over-the-Wire Micro-Guide Catheter Market: Information by, Application (Cardiovascular {Angiography, Angioplasty, Peripheral Stenting and others}, Neurovascular {Intracranial Aneurysms, Percutaneous Neuro Interventional Procedures and others} and others), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research & Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Over-the-wire Micro Guide Catheter (OTW Micro Guide Catheter) is a thin tubular Medical device inserted into the body for diagnosis or treatments of diseases like cardiovascular, neurovascular, and urology. Specially designed to ease complex procedures, OTW Micro Guide Catheter combining excellent cross-ability and optimal guide-wire support, can effectively treat challenging cases involving tortuous vessels, CTO (chronic total occlusions), bifurcations, and highly stenosed and calcified lesions, giving the high success rate.

OTW Catheters are widely used in cardiovascular applications such as peripheral and coronary interventions and neurovascular interventional applications. The high success rate associated with the use of these catheters further augments its uptake and demand, resultantly driving its market growth.

According to Market Research Future (MRFR)’s global Over-the-wire Micro Guide Catheters market Forecast, the industry is expected to grow at a CAGR of 9.37% during the forecast period (2018–2023).

According to reports published by the Centers for Disease Control and Prevention, the coronary heart disease is the most common type of heart diseases that accounted for the death of about 366,000 people in 2015.

Over-the-wire catheters comparatively make a better choice to treat a brain aneurysm than the rapid exchange catheters owing to their capabilities of extra pushing to enter stenose vessels, and additional support that they provide.

The increasing occurrences of coronary heart diseases, neurovascular diseases, hypertension, and other metabolic disorders, raising awareness for health, advancement in technologies, good healthcare infrastructure, and favorable reimbursement policies are fueling the market growth. 

Regional Analysis

The global over-the-wire micro guide catheters market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the global market leader for over-the-wire Micro-guide catheters. As per the study published in the Surgical Neurology International in 2017, it was found that more than 3% population of the United States equivalent to nearly 10 million individuals have a brain aneurysm. North America commands for the major share of the market whereas; South America show the fastest growth of the market due to the presence of boundless growth opportunities.

Europe OTW Micro Guide Catheter market holds the second position, globally. This is primarily attributable to the increasing prevalence of obesity as well as the increased incidence rate of hypertension and diabetes, which in turn is escalating cardiovascular traumas and cardiac arrest. Each year 15% of deaths in Europe occur due to cardiovascular diseases claims a study conducted by European Society of Cardiology.

The Asia Pacific region is the fastest growing market for the over-the-wire micro guide catheters. The region presents significant growth opportunities for market players as local policy makers continue to restructure the policy framework for the healthcare sector.

Global OTW Micro Guide Catheter Market: Segmentation

The global over-the-wire micro guide catheters market is segmented on the basis of applications and end-users. On the basis of applications, it is segmented into cardiovascular and neurovascular. By the cardiovascular, it is segmented into angiography, angioplasty, peripheral stenting, and others. On the basis of the neurovascular, it is segmented into intracranial aneurysms, percutaneous neurointerventional procedures, and others. Based on end-user the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.  

Major Players in the Over-the-wire Micro Guide Catheters Market

Enki – Microtubes, Cardinal Health, DePuy Synthes, Koninklijke Philips N.V, Penumbra Inc., Terumo Europe N.V., Integer Holdings Corporation, Merit Medical Systems Inc., Teleflex Incorporated, Cook Medical, Boston Scientific Corporation, Asahi Intecc Company Limited, and Medtronic plc.

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

Cranial Fixation and Stabilization Market 2019: Global Industry Analysis and Opportunity Assessment, Forecast to 2025

This cranial fixation and stabilization devices market growth can be attributed to the growing healthcare market and the ever-expanding technology market. Advances in these fields have created an environment that is conducive to the development of specialized surgical procedures for traditionally high-risk surgeries.

According to the UN, globally, one in six individuals suffers from a neurological disorder. There are several invasive surgeries that being developed to treat such conditions, requiring cranial fixation and stabilization equipment.

The Global Cranial Fixation and Stabilization Market value is expected to reach USD 2.29 Billion by 2025, registering a CAGR of 8.90%.

SEGMENTATION

By Category

Cranial stabilization equipment is used to secure the head during surgery, while cranial fixation implements are tools required to maintain the structural stability of the head and neck.

• Cranial Fixation Systems: Cranial fixation covers a wide array of tools and implements such as meshes, flap tube clamps, plates, and screws to be used during surgery. They are used predominantly for affixing bones, securing skin, and enhancing cranial integrity post-surgeries such as craniotomies.

• Cranial Stabilization Systems: Cranial surgeries are usually very delicate and complex, necessitating the use of equipment to immobilize the head. This is accomplished by the use of cranial stabilization equipment such as skull clamps and horseshoe headrests.

By Product

• Meshes: The leading market segment as 48% of all cranial injuries are maxillofacial. Over 52% of road accident-related injuries are mandibular fractures that require meshes.

• Skull Clamps: Ideal for prolonged surgeries that require patient immobilization for long periods with limited soft tissue damage. Used to hold the head firmly in place during surgery.

• Flap Tube Clamps: Used to attach cranial bones to the cranium during delicate surgeries when only a singular motion can be performed upon the afflicted area.

• Horseshoe Headrests: Used in cases where head movement is not to be completely restrained and soft tissue damage needs to be minimized.

• Plates: Used to seal gaping cranial wounds.

• Screws: Facilitate the attachment of cranial bones.

• Accessories: Include patient positioning systems and support systems.

By Type

• Resorbable: Materials that are eventually broken down by the body. The growth of the segment is limited by the high costs of the equipment.

• Non-Resorbable: These are biocompatible and offer unparalleled rigidity and stability to the cranium. Used extensively in developing countries due to their low costs.

By End User

• Hospitals: The segment commands the largest share of the global cranial fixation and stabilization market as most cranial surgeries are performed in hospitals. Cranial surgeries require the latest equipment and amenities, along with a high level of expertise, which are offered by hospitals.

• Ambulatory Surgical Centers: As emergency and temporary patient-stabilization surgeries are performed at these centers, the segment accounts for a small market share, which is somewhat offset by the higher revenue per surgery generated.

• Others: This segment includes on-site trauma and emergency surgeries. This is a niche segment with growth potential due to the establishment of trauma centers at industrial complexes.

 By Region

• Americas: Largest regional market, with North America accounting for 55% of the global market share.
• Asia-Pacific: Fastest growing regional market
• Europe: Second-largest market
• Middle East & Africa

Key Players

• Johnson & Johnson (US)
• Stryker (US)
• Ostomed (UK)
• KLS Martin Group (Germany)
• Medtronic (US)
• Integra LifeSciences Corporation (US)
• Braun Melsungen AG (Germany)
• Changzhou Huida (China)
• DePuy Synthes (US)
• Evonos (Germany)
• Jeil Medical (South Korea)
• Medicon (Germany)
• Micromar (Brazil)
• NEOS Surgery (Spain)
• Pro Med Instruments (Germany)
• Zimmer Biomet (US)

Browse More Healthcare Services @ https://www.marketresearchfuture.com/categories/healthcare-services

Herbal Medicine Market Global Sales, Revenue, Price and Gross Margin Forecast To 2023

Herbal Medicine Industry report anlayzes Herbal Medicine Market for Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Beauty Products and Herbal Dietary Supplements), by Type of Medicinal Plants (Marrubium Vulgare, Vaccinium Macrocarpon, Echinacea, Curcuma Longa, Camellia Sinensis, Actaea Racemose, Aloe Vera, Zingiber Officinale, Cocos Nucifera, Cinnamomum Spp and Allium Sativum), by Form (Extracts, Powders, Capsules & Tablets and Syrups), by Source (Leaves, Root & Barks, Whole Plants and Fruits), by Distribution Channel and by Region and Forecast till 2023

The Global Herbal Medicine Market value is expected to register a CAGR of 5.88% to reach USD 1,29,689.3 million by 2023.

Herb is a plant or plant part used for its scent, flavor, or therapeutic properties. Herbal medicines are a type of dietary supplements. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dried plants. People use herbal medicines to maintain and improve their health. Many conventional drugs originate from plant sources, and most of the few effective drugs are plant-based. Examples include aspirin (from willow bark), digoxin (from foxglove), quinine (from cinchona bark), and morphine (from the opium poppy). The development of drugs from plants continues, with drug companies engaged in the large-scale pharmacologic screening of herbs.

Key Players

The prominent players in the global herbal medicine market are Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp, and Arizona Natural Products among other.

Some of the key strategies followed by the players operating in the global herbal medicine market were innovation, product development, acquisition, and expansion.

Market Dynamics

Herbal medicines are used since ancient times for numerous health conditions. It is the oldest and most extensively used system of medicine in the world today. There are various kinds of herbal medicines and supplements used across the world. According to the National Center for Biotechnology Information, 2015, the World Health Organization (WTO), reported that around 70% to 80% of people globally rely on herbal sources for their treatment. Also, according to the American Botanical Council, September 2017, it was reported that in 2016, the sale of herbal supplements increased by 7.7% in the US. It was also estimated that consumers spending on herbal supplements increased to USD 7.452 billion in 2016. Thus, the increase in the demand for herbal products for healthcare purposes is likely to enhance this market during the forecast period.

Segmentation

The global herbal medicine Market, by category, is segmented into herbal pharmaceuticals, herbal dietary supplements, herbal functional foods, and herbal beauty products. The herbal pharmaceutical segment led the herbal medicine market with USD 50,972.4 million in 2017. The herbal pharmaceutical segment is growing owing to the increasing research and development on various herbs to find their medicinal properties, growing demand for natural medicines having fewer side-effects, and rising prevalence of chronic diseases such as diabetes, arthritis, cancer, sleep disorders, and digestive problems.

Marrubium vulgare segment is the fastest-growing segment of the market at CAGR of 6.45% during the forecast period. Marrubium vulgare also known as white horehound is a largely cultivated plant, and its above-ground parts are used for medicinal use. The upper part of the plant is used in powder, liquid extract, or juice form for medicinal purposes. Marrubium vulgare is largely used for digestion problems which include indigestion, loss of appetite, gas, bloating, diarrhea, constipation, and gallbladder complaints. It is also used for the treatment of breathing problems

The global herbal medicine Market, by form, is segmented into extracts, powders, capsules and tablets, syrups, and others. The extracts segment accounted for the largest market share of 36.95% in 2017.

The global herbal medicine Market, by source, is segmented into leaves, fruit, roots, and barks whole plant, and others (combinations of various plant parts). On the basis of source, the leaves segment is expected to lead the global herbal medicine market. The leaves segment held a share of USD 51,495.2 million in 2017.

The global herbal medicine Market, by distribution channel, is segmented into hospital and retail pharmacies, e-commerce, and others. The hospital & retail pharmacies segment accounted for the largest market share of 55.82% in 2017. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the herbal medicine market.

Regional Analysis

Europe is expected to account for the largest market share owing to extensive R&D for herbal medicine, increasing funding for research on medicinal plants, and growing preference for herbal drugs globally. On a regional basis, Europe is segmented into Western Europe and Eastern Europe. Western Europe is estimated to lead market growth during the forecast period. The increasing prevalence of chronic diseases and rising government support facilitate market growth within the region.

Americas accounts for the second largest share in the global herbal medicine market. It accounted for a considerable market share of 16.2% as of 2017. The use of herbal medicines is also growing in the US after conducting the first national study of alternative and complementary medicines used by Eisenberg et al. According to the National Center for Biotechnology Information 2017, it was reported that herbal supplements were majorly used for conditions such as cancer (43.1%), stroke (48.7%), and arthritis (43%) in the US. Such a high demand and preference for herbal products is likely to boost the market growth during the forecast period.

Asia-Pacific is expected to register a CAGR of 5.99% during the forecast period owing to the adoption of traditional medicines by pharmaceutical companies, researchers, and policymakers. On the other hand, the Middle East and Africa are expected to observe a slow growth due to less awareness and in-depth knowledge about herbal drugs in this region.

Browse More Pharmaceutical Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report